102 related articles for article (PubMed ID: 36412402)
1. The tolerance to chemoradiation for cervical cancer patients: A comparative prospective study of rural versus urban population.
Somashekar MK; Gururajachar JM; Arul Ponni TR; Koushik KA; Alva RC
J Cancer Res Ther; 2022; 18(6):1513-1517. PubMed ID: 36412402
[TBL] [Abstract][Full Text] [Related]
2. Correlation of skeletal muscle depletion with acute toxicities for cervical cancer patients undergoing concurrent chemoradiation: A prospective study.
Kumar SA; Gururajachar MJ; Martin VP
J Cancer Res Ther; 2022; 18(6):1525-1529. PubMed ID: 36412404
[TBL] [Abstract][Full Text] [Related]
3. Can pure accelerated radiotherapy given as six fractions weekly be an option in locally advanced carcinoma cervix: Results of a prospective randomized phase III trial.
Sharma M; Revannasiddaiah S; Gupta M; Seam RK; Gupta MK; Rastogi M
J Cancer Res Ther; 2016; 12(1):103-8. PubMed ID: 27072219
[TBL] [Abstract][Full Text] [Related]
4. Pre-treatment MRI minimum apparent diffusion coefficient value is a potential prognostic imaging biomarker in cervical cancer patients treated with definitive chemoradiation.
Marconi DG; Fregnani JH; Rossini RR; Netto AK; Lucchesi FR; Tsunoda AT; Kamrava M
BMC Cancer; 2016 Jul; 16():556. PubMed ID: 27469349
[TBL] [Abstract][Full Text] [Related]
5. Chemoradiation with and without adjuvant extrafascial hysterectomy for IB2 cervical carcinoma.
Darus CJ; Callahan MB; Nguyen QN; Pastore LM; Schneider BF; Rice LW; Jazaeri AA
Int J Gynecol Cancer; 2008; 18(4):730-5. PubMed ID: 17949426
[TBL] [Abstract][Full Text] [Related]
6. What to expect from immediate salvage hysterectomy following concomitant chemoradiation and image-guided adaptive brachytherapy in locally advanced cervical cancer.
Castelnau-Marchand P; Chargari C; Bouaita R; Dumas I; Farha G; Kamsu-Kom L; Rivin Del Campo E; Martinetti F; Morice P; Haie-Meder C; Mazeron R
Cancer Radiother; 2015 Dec; 19(8):710-7. PubMed ID: 26508320
[TBL] [Abstract][Full Text] [Related]
7. A comparison of six fractions per week chemoradiation versus five fractions per week of conventional chemoradiation in carcinoma cervix: A prospective controlled study.
Kumar D; Pradhan S; Choudhary S; Aggarwal LM; Das A; Sarangdhar S; Kaser P; Dewangan S
J Cancer Res Ther; 2019; 15(6):1296-1303. PubMed ID: 31898663
[TBL] [Abstract][Full Text] [Related]
8. Is neo-adjuvant chemotherapy a better option for management of cervical cancer patients of rural India?
Dastidar GA; Gupta P; Basu B; Basu A; Shah JK; Seal SL
Indian J Cancer; 2016; 53(1):56-9. PubMed ID: 27146741
[TBL] [Abstract][Full Text] [Related]
9. Role of Surgical Versus Clinical Staging in Chemoradiated FIGO Stage IIB-IVA Cervical Cancer Patients-Acute Toxicity and Treatment Quality of the Uterus-11 Multicenter Phase III Intergroup Trial of the German Radiation Oncology Group and the Gynecologic Cancer Group.
Marnitz S; Martus P; Köhler C; Stromberger C; Asse E; Mallmann P; Schmidberger H; Affonso Júnior RJ; Nunes JS; Sehouli J; Budach V
Int J Radiat Oncol Biol Phys; 2016 Feb; 94(2):243-53. PubMed ID: 26853333
[TBL] [Abstract][Full Text] [Related]
10. The effects of two HDR brachytherapy schedules in locally advanced cervical cancer treated with concurrent chemoradiation: a study from Chiang Mai, Thailand.
Tharavichitkul E; Klunkin P; Lorvidhaya V; Sukthomya V; Chakrabhandu S; Pukanhaphan N; Chitapanarux I; Galalae R
J Radiat Res; 2012; 53(2):281-7. PubMed ID: 22510600
[TBL] [Abstract][Full Text] [Related]
11. Socio-demographic and behavioural risk factors for cervical cancer and knowledge, attitude and practice in rural and urban areas of North Bengal, India.
Raychaudhuri S; Mandal S
Asian Pac J Cancer Prev; 2012; 13(4):1093-6. PubMed ID: 22799287
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant hysterectomy following primary chemoradiation for stage IB2 and IIA2 cervical cancer: a retrospective comparison of complications for open versus minimally invasive surgery.
Miller H; Matsuo K; Roman LD; Yessaian AA; Pham HQ; Hom M; Castaneda A; Pham A; Ragab O; Muderspach L; Ciccone M; Brunette LL
Radiat Oncol; 2021 Jun; 16(1):123. PubMed ID: 34187504
[TBL] [Abstract][Full Text] [Related]
13. Patterns of failure after use of (18)F-FDG PET/CT in integration of extended-field chemo-IMRT and 3D-brachytherapy plannings for advanced cervical cancers with extensive lymph node metastases.
Chung YL; Horng CF; Lee PI; Chen FL
BMC Cancer; 2016 Mar; 16():179. PubMed ID: 26940959
[TBL] [Abstract][Full Text] [Related]
14. Compliance with and acute hematologic toxic effects of chemoradiation in indigent women with cervical cancer.
Abu-Rustum NR; Lee S; Correa A; Massad LS
Gynecol Oncol; 2001 Apr; 81(1):88-91. PubMed ID: 11277656
[TBL] [Abstract][Full Text] [Related]
15. Comparison of outcomes and side effects for neoadjuvant chemotherapy with weekly cisplatin and paclitaxel followed by chemoradiation vs. chemoradiation alone in stage IIB-IVA cervical cancer: study protocol for a randomized controlled trial.
Li J; Liu H; Li Y; Li J; Shen L; Long W; Yang C; Xu H; Xi W; Cai R; Feng W
Trials; 2022 Jan; 23(1):29. PubMed ID: 35012634
[TBL] [Abstract][Full Text] [Related]
16. Surgical versus clinical staging prior to primary chemoradiation in patients with cervical cancer FIGO stages IIB-IVA: oncologic results of a prospective randomized international multicenter (Uterus-11) intergroup study.
Marnitz S; Tsunoda AT; Martus P; Vieira M; Affonso Junior RJ; Nunes J; Budach V; Hertel H; Mustea A; Sehouli J; Scharf JP; Ulrich U; Ebert A; Piwonski I; Kohler C
Int J Gynecol Cancer; 2020 Dec; 30(12):1855-1861. PubMed ID: 33293284
[TBL] [Abstract][Full Text] [Related]
17. Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.
Kokka F; Bryant A; Brockbank E; Powell M; Oram D
Cochrane Database Syst Rev; 2015 Apr; (4):CD010260. PubMed ID: 25847525
[TBL] [Abstract][Full Text] [Related]
18. Outcome and toxicity of radical radiotherapy or concurrent Chemoradiotherapy for elderly cervical cancer women.
Wang W; Hou X; Yan J; Shen J; Lian X; Sun S; Liu Z; Meng Q; Wang D; Zhao M; Qiu J; Hu K; Zhang F
BMC Cancer; 2017 Aug; 17(1):510. PubMed ID: 28764676
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of patients with cervical cancer treated with low- or high-dose rate brachytherapy after concurrent chemoradiation.
Scott AA; Yarney J; Vanderpuye V; Akoto Aidoo C; Agyeman M; Boateng SN; Sasu E; Anarfi K; Obeng-Mensah T
Int J Gynecol Cancer; 2021 May; 31(5):670-678. PubMed ID: 33558421
[TBL] [Abstract][Full Text] [Related]
20. Radical hysterectomy after chemoradiation in FIGO stage III cervical cancer patients versus chemoradiation and brachytherapy: Complications and 3-years survival.
Fanfani F; Vizza E; Landoni F; de Iaco P; Ferrandina G; Corrado G; Gallotta V; Gambacorta MA; Fagotti A; Monterossi G; Perrone AM; Lazzari R; Colangione SP; Scambia G
Eur J Surg Oncol; 2016 Oct; 42(10):1519-25. PubMed ID: 27241922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
